Hitesh Chandwani | Regional (Asia-Pacific) Market Access Director
Janssen Asia-Pacific | Singapore

Hitesh Chandwani, Regional (Asia-Pacific) Market Access Director, Janssen Asia-Pacific

Hitesh is the Asia-Pacific Market Access Director for Janssen's  Multiple Myeloma portfolio. In this role, he focuses on the integrated access and pricing strategies for Janssen's key assets in Multiple Myeloma including Darzalex, CAR-T as well as future pipeline products.

Prior to Janssen, Hitesh spent 7 years at Allergan (now part of AbbVie) in various roles, his last one being the New Product Portfolio and Market Access Strategy Lead for Allergan's Glaucoma & Ocular Surface portfolio, responsible for the creation of pipeline commercial and access strategies and corresponding product life-cycle plans for international markets, excluding the US. Prior to that, Hitesh worked in Global, Regional (APAC), and country (Australia, China) HEOR roles.

Hitesh is a physician and received his medical degree (MBBS) from King Edward VII Memorial Hospital in Mumbai, India. Additionally, he has a PhD in Health Outcomes and Pharmacy Practice from the University of Texas at Austin, USA.


Phar East 2020 Agenda Day Two @ 11:00

Panel: Adapting to the changing market access landscape

last published: 09/Dec/20 03:45 GMT

back to speakers






For speaking, sponsorship and exhibition opportunities contact jonathan.mottram@terrapinn.com
Tel: +65 6322 2738